How Stock Market is Valuing Vaccine Rollout

This weekend marked a historic day in the fight against the Coronavirus. The first shipment of the Pfizer’s (NYSE: PFE) BioNTech vaccine is now out for delivery.

Around three million doses will ship across the country in the next few days.

Canada also received its first batches of the COVID-19 vaccine ahead of its planned first stage of immunizations this week.

The vaccine needs to maintain a core temperature of -94°F, so the world is hopeful that the shipping containers fit with dry ice and GPS-enabled temperature sensors will do the job.

State health officials have asked Congress for at least $8.4 billion to carry out the largest immunization campaign the country has ever seen.

So, how does all this news factor into stock market prices? Will the supply chain for Pfizer and other company vaccines hold up? Will the economy start to recover and catch up with the exuberance of the stock market?

Watch the full interview to answer these questions and more…

Original article: How Stock Market is Valuing Vaccine Rollout

©2020 Midas Letter. All Rights Reserved.